Table 1.
Proportion of seropositivity for antibodies against LID-1, NDO-LID, NDO-HSA and PGL-1 according to groups of individuals
| No. (%) positivea | ||||||
|---|---|---|---|---|---|---|
| No. of samples | LID-1 | NDO-LID | NDO-HSA | PGL-1 | ||
| Patients | MB | 43 | 34(89.5) | 38(71.7) | 33(76.7) | 38(66.7) |
| PB | 51 | 4(10.5) | 15(28.3) | 10(23.3) | 19(33.3) | |
| HHC | MBb | 81 | 35(43.2) | 31(38.3) | 10(12.3) | 14(17.3) |
| PBc | 23 | 6(26.1) | 6(26.1) | 0(0.0) | 1(4.3) | |
| GPop | 2494 | 74(21.9) | 995(41.2) | 191(7.9) | - | |
aTest were considered positive when a distinct band was observed (scored as EI of 1.1 or greater)
bHHC of patients classified as MB
cHHC of patients classified as PB